When Big Pharma Walks Away: What Abandoned Patents Reveal About Pipeline Priorities
In the high-stakes world of pharmaceutical innovation, the decision to abandon a patent isn’t just a footnote—it’s a window into the shifting priorities and strategic recalibrations of Big Pharma. As industry giants pivot, divest, or retreat from certa…
When Big Pharma Walks Away: What Abandoned Patents Reveal About Pipeline Priorities Read Post »
